MACUGEN Solution for injection Ref.[9039] Active ingredients: Pegaptanib

Source: European Medicines Agency (EU)  Revision Year: 2019  Publisher: PharmaSwiss Česká republika s.r.o., Jankovcova 1569/2c, 170 00 Praha 7, Czech Republic

Product name and form

Macugen 0.3 mg solution for injection.

Pharmaceutical Form

Solution for injection (injection).

The solution is clear and colourless.

Qualitative and quantitative composition

One pre-filled syringe provides a usable amount to deliver a single dose of 90 microlitres containing pegaptanib sodium, corresponding to 0.3 mg of the free acid form of the oligonucleotide.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Pegaptanib

Pegaptanib is a pegylated modified oligonucleotide that binds with high specificity and affinity to extracellular Vascular Endothelial Growth Factor (VEGF165) inhibiting its activity. VEGF is a secreted protein that induces angiogenesis, vascular permeability and inflammation, all of which are thought to contribute to the progression of the neovascular (wet) form of AMD.

List of Excipients

Sodium chloride
Monobasic sodium phosphate monohydrate
Dibasic sodium phosphate heptahydrate
Sodium hydroxide (for pH adjustment)
Hydrochloric acid (for pH adjustment)
Water for injections

Pack sizes and marketing

Each pack contains a pouch in a carton containing a 1 ml pre-filled syringe, Type 1 glass, sealed with an elastomeric (brombutyl rubber) plunger stopper and a pre-attached plunger rod, held by a plastic clip. The syringe has a pre-attached polycarbonate plastic luer lock adaptor and the tip is sealed with an elastomeric (bromobutyl/synthetic isoprene) tip cap.

Each pre-filled syringe contains approximately 0.25-0.27 ml of solution.

Each carton contains one pre-filled syringe in a pouch (single dose pack).

The pack is supplied without a needle.

Marketing authorization holder

PharmaSwiss Česká republika s.r.o., Jankovcova 1569/2c, 170 00 Praha 7, Czech Republic

Marketing authorization dates and numbers

EU/1/05/325/002

Date of first authorisation: 31/01/2006

Date of latest renewal: 19/11/2015

Drugs

Drug Countries
MACUGEN Lithuania, Romania, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.